THIS STUDY HAS NOW ENDED
The Overdale Medical Practice are excited to be taking part in this University of Oxford research study to find out whether we can improve care for people with asthma using a breath test called FeNO. The practice will begin inviting eligible patients from week commencing 26th June 2023. Patients who would like to take part will be asked to book an appointment at the surgery from week commencing 21st August 2023. If you have received an invite please read all the information below and complete the FeNO study consent form at the bottom of this page.
Determining the Effectiveness of a FeNO-guided asthma management INtervEntion in primary care (DEFINE) is a research study conducted by the University of Oxford.
Its aim is to help health care professionals in GP surgeries provide a more personalised approach to managing patients’ asthma by using FeNO to guide decisions about their treatment.
FeNO stands for Fractional Exhaled Nitric Oxide and is measured using a simple breath test.
Nitric oxide is a gas which everyone breathes out. People with inflamed airways breathe out more nitric oxide than people whose airways are not inflamed. These patients are more likely to have an asthma attack if their inflammation remains untreated.
FeNO is already measured in patients with severe asthma who are seen in hospital clinics. However, very few GP surgeries routinely use FeNO to help them monitor treatment.
A copy of the FeNO Patient Booklet can be found below:
FeNo Patient Booklet
Patient demonstration Video
If you or your child would like to take part in this research project and have received an invite, please see the Research Information Sheets below for more information: